<span class="paragraphSection">In the 1960s and 1970s hepatitis as a result of blood transfusion was relatively common, but at a recent talk on recent advances in the treatment of hepatitis I was surprised to learn just how high the mortality was after blood transfusion during this time period. In the USA an epidemiological study reported that 6% of nearly 30,000 patients with viral hepatitis had received one or more transfusions of blood or blood product within two weeks to six months before the onset of symptoms and the mortality in these patients was around 10%.<a href="#aew405-B1" class="reflinks"><sup>1</sup></a> In the yrs to come there were also new and emerging viruses and prions to add to the problem. On searching the more recent literature however, there are many reports which still highlight higher mortality in patients who have had blood transfusions. Two immediate questions spring to mind: 1. Are there problems associated with the transfusion itself or 2. Does the original need for a transfusion result in increased mortality?</span>
http://ift.tt/2kVO4kN
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Πέμπτη 16 Φεβρουαρίου 2017
Stranger danger—mortality after transfusions
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου